{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:37:13Z","timestamp":1793893033208,"version":"4.8.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"IMI","doi-asserted-by":"publisher","award":["101034420"],"award-info":[{"award-number":["101034420"]}],"id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.cmi.2023.09.001","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T12:51:32Z","timestamp":1696423892000},"page":"S14-S25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"S1","title":["A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe"],"prefix":"10.1016","volume":"30","author":[{"given":"Nasreen","family":"Hassoun-Kheir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Therese","family":"Ngo Nsoga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Argante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Arieti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beryl P.","family":"Gladstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhys","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichola R.","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria D.","family":"Pezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen B.","family":"Pouwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie V.","family":"Robotham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venanzio","family":"Vella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Harbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlieke E.A.","family":"de Kraker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Barana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"De Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa A.","family":"El-Abasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Galia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Geurtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorly","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alen","family":"Piljic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya Babu","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Reyna-Villasmil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.09.001_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2023.09.001_bib2","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1016\/S2468-2667(22)00225-0","article-title":"The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.cmi.2023.09.001_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nm.4465","article-title":"The role of vaccines in preventing bacterial antimicrobial resistance","volume":"24","author":"Jansen","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2023.09.001_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/antibiotics9040155","article-title":"Monoclonal antibodies as an antibacterial approach against bacterial pathogens","volume":"9","author":"Zurawski","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2023.09.001_bib6","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S2666-5247(22)00303-2","article-title":"The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline","volume":"4","author":"Frost","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.cmi.2023.09.001_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282276","article-title":"Clinical predictors of mortality in patients with pseudomonas aeruginosa infection","volume":"18","author":"Frem","year":"2023","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.09.001_bib8","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1038\/srep11715","article-title":"Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2023.09.001_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1473-3099(10)70258-9","article-title":"Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study","volume":"11","author":"Lambert","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib10","author":"Hassoun-Kheir"},{"key":"10.1016\/j.cmi.2023.09.001_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002150","article-title":"Burden of six healthcare-associated infections on European population health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study","volume":"13","author":"Cassini","year":"2016","journal-title":"PLOS Med"},{"key":"10.1016\/j.cmi.2023.09.001_bib12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cmi.2021.01.004","article-title":"Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria","volume":"27","author":"Pezzani","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib13","series-title":"Antimicrobial resistance in the EU\/EEA (EARS-Net) \u2013 annual epidemiological report ECDC","year":"2019"},{"key":"10.1016\/j.cmi.2023.09.001_bib15","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.cmi.2023.09.001_bib16","unstructured":"JBI. JBI Critical appraisal tools. South Australia; 2018: The University of Adelaide; 2022. https:\/\/jbi.global\/critical-appraisal-tools. [Accessed 6 May 2022]"},{"key":"10.1016\/j.cmi.2023.09.001_bib17","unstructured":"Boutron I.P.M., Higgins J.P.T., Altman D.G., Lundh A., Hr\u00f3bjartsson A. Chapter 7: considering bias and conflicts of interest among the included studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Available from www.training.cochrane.org\/handbook. [Accessed 30 Jun -2023]"},{"key":"10.1016\/j.cmi.2023.09.001_bib18","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.09.001_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.cmi.2023.09.001_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.01.001","article-title":"Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England","volume":"21","author":"Abernethy","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jhin.2021.11.021","article-title":"Vancomycin-resistant enterococcus bacteraemia in an endemic region: clinical features and genomic analysis: a 12-year cohort","volume":"121","author":"Abu-Lybdeh","year":"2022","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1086\/605555","article-title":"Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries","volume":"49","author":"Ammerlaan","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib23","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1017\/ice.2018.181","article-title":"The epidemiological impact and significance of carbapenem resistance in Pseudomonas aeruginosa bloodstream infections: a matched case-case-control analysis","volume":"39","author":"Aviv","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2023.09.001_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170236","article-title":"Characteristics of Staphylococcus aureus Bacteraemia and predictors of early and late mortality","volume":"12","author":"Bassetti","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.09.001_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1469-0691.2011.03478.x","article-title":"Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections","volume":"18","author":"Ben-David","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0732-8893(99)00136-4","article-title":"A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia","volume":"36","author":"Bhavnani","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jhin.2018.10.024","article-title":"Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011\u20132015 data from West London","volume":"101","author":"Blandy","year":"2019","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1471-2334-14-353","article-title":"Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia","volume":"14","author":"Cheah","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib29","doi-asserted-by":"crossref","first-page":"ofab616","DOI":"10.1093\/ofid\/ofab616","article-title":"Contemporary clinical and molecular epidemiology of vancomycin-resistant enterococcal bacteremia: a prospective multicenter cohort study (VENOUS I)","volume":"9","author":"Contreras","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib30","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/AAC.00782-08","article-title":"Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections","volume":"53","author":"Daikos","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2023.09.001_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jhin.2006.09.022","article-title":"Epidemiology, clinical and laboratory characteristics of Staphylococcus aureus bacteraemia in a university hospital in UK","volume":"65","author":"Das","year":"2007","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib32","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1128\/AAC.01157-10","article-title":"Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections","volume":"55","author":"de Kraker","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2023.09.001_bib33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/jac\/dkq412","article-title":"Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins","volume":"66","author":"de Kraker","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2023.09.001_bib34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12879-020-05262-6","article-title":"Modifiable healthcare factors affecting 28-day survival in bloodstream infection: a prospective cohort study","volume":"20","author":"Evans","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230501","article-title":"Low incidence of antibiotic-resistant bacteria in south-east Sweden: an epidemiologic study on 9268 cases of bloodstream infection","volume":"15","author":"Holmbom","year":"2020","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.09.001_bib36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jmii.2011.12.009","article-title":"Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia","volume":"45","author":"Huang","year":"2012","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jhin.2012.10.012","article-title":"Impact of carbapenem resistance on the outcome of patients\u2019 hospital-acquired bacteraemia caused by Klebsiella pneumoniae","volume":"83","author":"Hussein","year":"2013","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib38","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.ajic.2018.05.003","article-title":"Patient- and hospital-level predictors of vancomycin-resistant Enterococcus (VRE) bacteremia in Ontario, Canada","volume":"46","author":"Johnstone","year":"2018","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.cmi.2023.09.001_bib39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/mdr.2010.0170","article-title":"Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome","volume":"17","author":"Joo","year":"2011","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.cmi.2023.09.001_bib40","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.3346\/jkms.2021.36.e273","article-title":"Antimicrobial susceptibility trends and risk factors for antimicrobial resistance in Pseudomonas aeruginosa bacteremia: 12-year experience in a tertiary hospital in Korea","volume":"36","author":"Kang","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"7","key":"10.1016\/j.cmi.2023.09.001_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02180-19","article-title":"Impact of vanA-positive Enterococcus faecium exhibiting diverse susceptibility phenotypes to glycopeptides on 30-day mortality of patients with a bloodstream infection","volume":"64","author":"Kim","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2023.09.001_bib42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3346\/jkms.2012.27.5.471","article-title":"Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy","volume":"27","author":"Kim","year":"2012","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.cmi.2023.09.001_bib43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1471-2334-14-161","article-title":"Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jac\/dkl499","article-title":"Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia","volume":"59","author":"Kwon","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2023.09.001_bib45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/501624","article-title":"Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality","volume":"20","author":"Lautenbach","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2023.09.001_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/IDR.S56984","article-title":"Mortality and molecular epidemiology associated with extended-spectrum \u03b2-lactamase production in Escherichia coli from bloodstream infection","volume":"7","author":"Leistner","year":"2014","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.cmi.2023.09.001_bib47","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1128\/AAC.00115-10","article-title":"Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms","volume":"54","author":"Mart\u00ednez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2023.09.001_bib48","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1086\/379321","article-title":"Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia","volume":"37","author":"Melzer","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib49","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jinf.2007.04.007","article-title":"Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli","volume":"55","author":"Melzer","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib50","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jinf.2018.08.015","article-title":"Survival following Staphylococcus aureus bloodstream infection: a prospective multinational cohort study assessing the impact of place of care","volume":"77","author":"Nambiar","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib51","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1128\/AAC.05991-11","article-title":"Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections","volume":"56","author":"Pe\u00f1a","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2023.09.001_bib52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12879-021-07024-4","article-title":"Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019","volume":"22","author":"Pogue","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib53","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1093\/jac\/dkaa361","article-title":"Outcome of community-onset ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and urinary tract infection: a population-based cohort study in Denmark","volume":"75","author":"Richelsen","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2023.09.001_bib54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/649537","article-title":"Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis","volume":"50","author":"Rodr\u00edguez-Ba\u00f1o","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib55","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1469-0691.2009.02902.x","article-title":"Cast of Resistance Study group. Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study","volume":"16","author":"Rubio-Terr\u00e9s","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib56","doi-asserted-by":"crossref","first-page":"115170","DOI":"10.1016\/j.diagmicrobio.2020.115170","article-title":"Do written diagnosis-treatment recommendations on microbiological test reports improve the management of Staphylococcus aureus bacteremia? A single-center, retrospective, observational study","volume":"98","author":"Schneider","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib57","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/infdis\/172.4.993","article-title":"Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections","volume":"172","author":"Shay","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib58","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1016\/j.ijid.2010.02.2254","article-title":"A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii","volume":"14","author":"Sheng","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0195-6701(03)00046-X","article-title":"Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment","volume":"54","author":"Smolyakov","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1556\/AMicr.56.2009.3.5","article-title":"Risk factors and outcomes for bloodstream infections with extended-spectrum beta -lactamase-producing Klebsiella pneumoniae; Findings of the nosocomial surveillance system in Hungary","volume":"56","author":"Szil\u00e1gyi","year":"2009","journal-title":"Acta Microbiol Immunol Hung"},{"key":"10.1016\/j.cmi.2023.09.001_bib61","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jhin.2008.07.004","article-title":"Contribution of acquired meticillin-resistant Staphylococcus aureus bacteraemia to overall mortality in a general intensive care unit","volume":"70","author":"Thompson","year":"2008","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224465","article-title":"Bloodstream infections caused by Escherichia coli in onco-haematological patients: risk factors and mortality in an Italian prospective survey","volume":"14","author":"Trecarichi","year":"2019","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.09.001_bib63","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ajh.24489","article-title":"Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey","volume":"91","author":"Trecarichi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cmi.2023.09.001_bib64","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-135-7-200110020-00007","article-title":"Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study","volume":"135","author":"Vergis","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2023.09.001_bib65","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00277-019-03607-z","article-title":"Bloodstream infections with vancomycin-resistant enterococci are associated with a decreased survival in patients with hematological diseases","volume":"98","author":"Weber","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cmi.2023.09.001_bib66","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/cid\/cix1076","article-title":"Antibiotic resistance and the risk of recurrent bacteremia","volume":"66","author":"Woudt","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/bmj.38834.421713.2F","article-title":"Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study","volume":"333","author":"Wyllie","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.09.001_bib68","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1086\/649020","article-title":"Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort","volume":"31","author":"Butler","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2023.09.001_bib69","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1093\/cid\/ciaa1228","article-title":"Attributable length of stay, mortality risk, and costs of bacterial health care-associated infections in Australia: a retrospective case-cohort study","volume":"72","author":"Lee","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib70","doi-asserted-by":"crossref","first-page":"30319","DOI":"10.2807\/1560-7917.ES.2016.21.33.30319","article-title":"The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study","volume":"21","author":"Stewardson","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2023.09.001_bib71","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/cid\/cis550","article-title":"Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Vydra","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib72","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijid.2019.05.004","article-title":"Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: description of a decade-long trend","volume":"85","author":"Balkhair","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib73","doi-asserted-by":"crossref","first-page":"O630","DOI":"10.1111\/1469-0691.12564","article-title":"Case fatality ratio and mortality rate trends of community-onset Staphylococcus aureus bacteraemia","volume":"20","author":"Tom","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.09.001_bib74","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/clinids\/21.6.1417","article-title":"Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus","volume":"21","author":"Romero-Vivas","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.001_bib75","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/epirev\/mxab001","article-title":"Burden of antimicrobial resistance: compared to what?","volume":"43","author":"de Kraker","year":"2022","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.cmi.2023.09.001_bib77","doi-asserted-by":"crossref","first-page":"1700513","DOI":"10.2807\/1560-7917.ES.2018.23.21.1700513","article-title":"PROHIBIT study group. Process and outcome indicators for infection control and prevention in European acute care hospitals in 2011 to 2012 \u2013 results of the PROHIBIT study","volume":"23","author":"Hansen","year":"2018","journal-title":"Euro Surveill"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23004196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23004196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:15:32Z","timestamp":1728864932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X23004196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":75,"alternative-id":["S1198743X23004196"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.09.001","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}